-
2024-519986-23-00
The study will involve adult women and men from 16 Fren 5
-
2024-513917-11-01
Adult patients with chronic lymphocytic leukemia/small 9
-
2024-519472-69-00
CML-Patients in chronic phase having failed a prior att 4
-
2025-523096-34-00
B-cell Acute Lymphoblastic Leukemia 5
-
2025-521827-61-00
refractory/relapsed multiple myeloma 4
-
2024-511567-28-01
Cancer 4
-
2023-509534-18-01
Myelom 4
-
2025-521836-12-00
deep vein thrombosis 4
-
2024-516570-30-00
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia 4
-
2024-513528-41-02
Sickle cell anaemia 5
-
2023-507537-16-00
Chimeric antigen receptor T cell therapy-associated cyt 9
-
2025-521322-14-00
Patients over 55 with Acute Myeloid Leukemia (AML) and 4
-
2024-518977-32-00
Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and n 5
-
2024-519009-36-01
Severe chronic neutropenia (SCN) 4
-
2024-520149-22-00
Lymphedema 7
-
2025-521962-83-00
Relapsed and/or refractory AML or MDS 9
-
2025-524181-26-00
relapsed/refractory multiple myeloma 4
-
2025-523355-59-00
Immune Thrombocytopenia, Hematopoietic Syndrome of Acut 2
-
2024-517583-36-01
High risk and very high risk acute leukemia/myelodyspla 4
-
2024-514073-22-01
Coagulation in pediatric cardiac surgery 5
-
2025-524265-24-00
Dyslipidemia at High to Very High Cardiovascular Risk 5 2026-05-21
-
2025-521074-34-00
Allogeneic peripheral hematopoietic stem cell transplan 4 2026-05-15
-
2024-511496-14-00
Newly Diagnosed Philadelphia Chromosome-Positive Acute 5 2026-05-14
-
2023-509590-23-00
Hemophilia B 5 2026-04-22